retatrutide weight loss trial data produces up to 30.3% in Phase 3 π¨ TRIUMPH-1: #retatrutide topline dataπ¨
Description
It is important to note that there is no definitive scientific consensus that these drugs directly cause pancreatitis, and the absolute risk appears to be low based on clinical trial data

Some platforms restructured to require demonstrated medical-need exemptions

Every production batch receives unique identification and comprehensive documentation including Certificate of Analysis detailing all test results, manufacturing date, expiration date, storage conditions, and lot traceability information

Check out if youre eligible for the trial here, and check out a webinar on the study in the blog

doi: 10.3390/nu11051136

Some providers cut prescribing as soon as you drop below BMI 25
